Showing 1 - 6 results of 6 for search 'Celia Camacho-Toledano', query time: 0.02s Refine Results
  1. 1
    Regulatory Cells in Multiple Sclerosis: From Blood to Brain

    Regulatory Cells in Multiple Sclerosis: From Blood to Brain by Leticia Calahorra, Celia Camacho-Toledano, Mari Paz Serrano-Regal, María Cristina Ortega, Diego Clemente

    Published 2022-02-01
    Get full text
    Article
  2. 2
    CIRCULATING MYELOID-DERIVED SUPPRESSOR CELLS AS A POTENTIAL BIOINDICATOR OF THE ENDOGENOUS MYELIN REPAIR CAPACITY IN EXPERIMENTAL MULTIPLE SCLEROSIS

    CIRCULATING MYELOID-DERIVED SUPPRESSOR CELLS AS A POTENTIAL BIOINDICATOR OF THE ENDOGENOUS MYELIN REPAIR CAPACITY IN EXPERIMENTAL MULTIPLE SCLEROSIS by Mari Paz Serrano-Regal, Inmaculada Alonso-García, Celia Camacho-Toledano, Isabel Machin-Diaz, María Cristina Ortega, Leticia Calahorra, Diego Clemente

    Published 2023-10-01
    Get full text
    Article
  3. 3
    EVOBRUTINIB TREATMENT REDUCES THE DAMAGE TO THE CNS AND INCREASES THE NUMBER OF CLASSICAL DENDRITIC CELLS IN EXPERIMENTAL MULTIPLE SCLEROSIS

    EVOBRUTINIB TREATMENT REDUCES THE DAMAGE TO THE CNS AND INCREASES THE NUMBER OF CLASSICAL DENDRITIC CELLS IN EXPERIMENTAL MULTIPLE SCLEROSIS by Mari Paz Serrano-Regal, Leticia Calahorra, Inmaculada Alonso-García, Ursula Boschert, Philipp Haselmayer, María Cristina Ortega, Isabel Machin-Diaz, Celia Camacho-Toledano, Jennifer García-Arocha, Diego Clemente

    Published 2023-10-01
    Get full text
    Article
  4. 4
    Tissue plasminogen activator worsens experimental autoimmune encephalomyelitis by complementary actions on lymphoid and myeloid cell responses

    Tissue plasminogen activator worsens experimental autoimmune encephalomyelitis by complementary actions on lymphoid and myeloid cell responses by Pauline Hélie, Celia Camacho-Toledano, Léonie Lesec, Célia Seillier, Antonio J. Miralles, Maria Cristina Ortega, Sylvaine Guérit, Héloïse Lebas, Isabelle Bardou, Virginia Vila-del Sol, Denis Vivien, Brigitte Le Mauff, Diego Clemente, Fabian Docagne, Olivier Toutirais

    Published 2021-02-01
    Get full text
    Article
  5. 5
    Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis

    Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis by Celia Camacho-Toledano, Isabel Machín-Díaz, Leticia Calahorra, María Cabañas-Cotillas, David Otaegui, Tamara Castillo-Triviño, Luisa María Villar, Lucienne Costa-Frossard, Manuel Comabella, Luciana Midaglia, José Manuel García-Domínguez, Jennifer García-Arocha, María Cristina Ortega, Diego Clemente

    Published 2022-11-01
    Get full text
    Article
  6. 6
    MYELOID-DERIVED SUPPRESSOR CELL BURDEN IN THE CNS AND BLOOD IS ASSOCIATED WITH DISEASE SEVERITY OF MULTIPLE SCLEROSIS PATIENTS

    MYELOID-DERIVED SUPPRESSOR CELL BURDEN IN THE CNS AND BLOOD IS ASSOCIATED WITH DISEASE SEVERITY OF MULTIPLE SCLEROSIS PATIENTS by María Cristina Ortega, Isabel Machin-Diaz, Michelle Naughton, Inmaculada Pérez-Molina, Jennifer García-Arocha, Jose Manuel García-Domínguez, Haydee García-Briceño, Rafael Lebron-Galan, Virginia Vila-Del Sol, Victor Quintanero-Casero, Rosa García-Montero, Victoria Galan, Leticia Calahorra, Celia Camacho-Toledano, Maria Luisa Martinez-Gines, Denise Fitzgerald, Diego Clemente

    Published 2023-10-01
    Get full text
    Article

Search Tools: